[Contribution of pure FSH in ovulation induction excluding fertilization in vitro].
The use of pure FSH reduces the likelihood of multifollicular development and increases the safety of ovulation induction without affecting the overall pregnancy rate. The authors propose a "slow" protocol, which is said to provide the same level of safety, but also to increase the number of pregnancies.
Buvat
J
J
Etude de la Pathologie de l'Appareil Reproducteur et de la Psychosomatique (EPARP), Lille.
Buvat-Herbaut
M
M
Marcolin
G
G
Verbecq
P
P
D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic; D002996:Clomiphene / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D005640:Follicle Stimulating Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy* / Q000209:etiology; D010062:Ovulation Induction / Q000379:methods* / Q000592:standards; D011085:Polycystic Ovary Syndrome / Q000150:complications*; D011247:Pregnancy; D011256:Pregnancy Outcome
D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone; D005640:Follicle Stimulating Hormone
Apport de la FSH pure dans l'induction de l'ovulation hors fécondation in vitro.